NDC 51759-208 – Epysqli
Eculizumab 300 mg/30mL · Injection, Solution · Intravenous
Product NDC51759-208
Product details
- Brand name
- Epysqli
- Generic name
- Eculizumab-aagh
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761340
- Marketed since
- April 7, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Complement Inhibitor
Active ingredients
- Eculizumab 300 mg/30mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51759-208-13 | 1 VIAL, SINGLE-DOSE in 1 CARTON (51759-208-13) / 30 mL in 1 VIAL, SINGLE-DOSE | Apr 7, 2025 |